Novel 5′-UTR Element Enhances mRNA Translation Efficiency

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current nucleic acid drugs face challenges in drug delivery and druggability, with mRNA vaccines and therapies requiring improved 5′-untranslated region (UTR) elements for enhanced protein expression and stability.

Innovation Solution

A novel artificial 5′-untranslated region element is developed by operably linking a transcription-enhancing sequence, a Kozac sequence, and a full-length or fragment sequence of a naturally highly expressed gene's 5′-UTR, optimized to exclude TOP motifs and uORFs, and incorporating a non-structural sequence that prevents secondary structure formation, enhancing mRNA translation efficiency and stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If natural 5′-UTR sequences are used, then mRNA stability is improved, but translation efficiency is limited

Engineering Contradiction:
ImprovemRNA stabilityVSAvoidtranslation efficiency
Core Design Contradiction:
Stability of the object's compositionVSProductivity

Solution Approach 1:

The patent creates a composite 5′-UTR element that combines multiple functional sequences: a transcription-enhancing sequence (AATAA), a Kozac sequence (GCCACC), and an optimized fragment from a naturally highly expressed gene. This composite structure integrates the stability-providing characteristics of natural sequences with translation-enhancing elements, achieving both mRNA stability and high translation efficiency that neither component could provide alone.

Inventive Principle:
Principle #40Composite materials

2Stability of the object's composition

If full-length natural 5′-UTR sequences are used, then mRNA stability is improved, but expression complexity increases

Engineering Contradiction:
ImprovemRNA stabilityVSAvoidsequence complexity
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The patent extracts and utilizes only the essential functional fragment of the natural 5′-UTR sequence that provides stability, while deliberately excluding non-essential elements such as TOP motifs and uORFs that would add complexity without providing proportional benefit. This extracted fragment approach maintains mRNA stability while simplifying the overall sequence design.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The 5′-UTR is segmented into distinct functional modules: a transcription-enhancing AATAA sequence, a Kozac GCCACC sequence for ribosome binding, and an optimized fragment from the natural gene. This segmentation allows each element to perform its specific function independently, reducing overall complexity while maintaining stability and translation efficiency.

Inventive Principle:
Principle #1Segmentation

3Reliability

If TOP motifs and uORFs are included, then natural sequence fidelity is maintained, but translation efficiency decreases

Engineering Contradiction:
Improvesequence fidelityVSAvoidtranslation efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent identifies that TOP motifs and uORFs, while part of natural sequences, actually reduce translation efficiency. By deliberately excluding these elements, the invention converts a potential harm (reduced translation) into a benefit (enhanced expression efficiency), while maintaining reliability through the use of transcription-enhancing AATAA sequences and proper Kozac sequences that ensure faithful translation initiation.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Data Source

PatentUS20250011770A1Novel 5'-untranslated region element and use thereof
Publication Date: 2025.01.09 THEMEDIUM THERAPEUTICS CO LTD
  • US20250011770A1 patent drawing
  • US20250011770A1 patent drawing

AI summary

A 5′-untranslated region element includes the full-length sequence of the 5′-untranslated region of a naturally highly expressed gene; or a fragment sequence of the 5′-untranslated region of a naturally highly expressed gene, wherein the fragment sequence of the 5′-untranslated region does not comprise a TOP motif site (e.g., CTTTT) or a uORF sequence (AUG upstream of an open reading frame); or a fragment sequence of the 5′-untranslated region of a naturally highly expressed gene, a non-structural sequence, a transcription-enhancing sequence, and a Kozac sequence, wherein the fragment sequence of the 5′-untranslated region lacks a TOP motif site or a uORF sequence. The 5′-untranslated region element of the present application makes nucleic acid molecules having extremely high protein expression performance and expression efficiency. The element is usable for constructing artificial nucleic acid molecules with high expression performance and has excellent application prospects in the development of nucleic acid therapeutic drugs.